HEP C - IDENTIFY RELAPSE RISKS AND REMEDIES

Zapisane w:

Opis bibliograficzny
1. autor:	DOLAN, M.
Format:	Journal Article
Język:	angielski
Hasła przedmiotowe:	Alcoholismo Detección Drogodependencias Factor de protección Hepatitis Recaída Tratamiento Vía intravenosa Adicciones Documental
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy: HEP C - IDENTIFY RELAPSE RISKS AND REMEDIES

Quick Look
HEP C: PRESCRIPTION FOR LIVING
Quick Look
RELAPSE TO INJECTING DRUG USE: A HEPATITIS C TREATMENT CONCERN
Quick Look
HEP C - IS THIS NEW EPIDEMIC GAINING PACE?
Quick Look
The 2016 Hep-CORE report
Quick Look
HEPATITIS C TESTING AND INJECTING RISK BEHAVIOUR: THE RESULTS OF A UK BASED PILOT STUDY
Quick Look
Predictors of treatment outcomes for Hepatitis C infection in a nationwide elimination program in Iceland: The treatment as prevention for Hepatitis C (TraP HepC) study
Quick Look
Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
Quick Look
USING DECISION TREE ANALYSIS TO IDENTIFY RISK FACTORS FOR RELAPSE TO SMOKING
Quick Look
HIGH PREVALENCE OF ALCOHOL USE AMONG HEPATITIS C VIRUS ANTIBODY POSITIVE INJECTION DRUG USERS IN THREE US CITIES
Quick Look
Cost-effectiveness of the HepCATT intervention in specialist drug clinics to improve case-finding and engagement with HCV treatment for people who inject drugs in England
Quick Look
INCIDENCE AND RISK FACTORS FOR HEPATITIS C SEROCONVERSION IN INJECTING DRUG USERS IN AUSTRALIA
Quick Look
THE AUSTRALIAN STUDY OF HIV AND INJECTING DRUG USE. PART II: PREDICTING EXPOSURE TO HEPATITIS C AND HEPATITIS B
Quick Look
CAN HEPATITIS C VIRUS PREVALENCE BE USED AS A MEASURE OF INJECTION-RELATED HUMAN IMMUNODEFICIENCY VIRUS RISK IN POPULATIONS OF INJECTING DRUG USERS?. AN ECOLOGICAL ANALYSIS
Quick Look
A PROSPECTIVE STUDY TO EXAMINE PERSISTENT HCV REINFECTION IN INJECTION DRUG USERS WHO HAVE PREVIOUSLY CLEARED THE VIRUS
Quick Look
ESTIMATING POPULATION ATTRIBUTABLE RISK FOR HEPATITIS C SEROCONVERSION IN INJECTING DRUG USERS IN AUSTRALIA: IMPLICATIONS FOR PREVENTION POLICY AND PLANNING
Quick Look
ACCEPTABILITY OF HEPATITIS C VIRUS TESTING METHODS AMONG INJECTING DRUG USERS
Quick Look
Acquiring hepatitis C in prison: the social organisation of injecting risk
Quick Look
TARGETS FOR HEPATITIS C VIRUS TEST UPTAKE AND CASE FINDING AMONG INJECTING DRUG USERS: IN PRISONS AND GENERAL PRACTICE
Quick Look
HEPATITIS C: TIME TO WAKE UP
Quick Look
THE UTILITY OF INDIRECT PREDICTORS OF HEPATITIS C VIREMIA
Quick Look
HEPATITIS C VIRUS RISK BEHAVIORS WITHIN THE PARTNERSHIPS OF YOUNG INJECTING DRUG USERS
Quick Look
SEROPREVALENCE OF HEPATITIS A, B, C, AND D MARKERS AND LIVER FUNCTION ABNORMALITIES IN INTRAVENOUS HEROIN ADDICTS
Quick Look
MODELING THE BEHAVIOR AND ATTRIBUTES OF INJECTING DRUG USERS: A NEW APPROACH TO IDENTIFYING HIV RISK PRACTICES
Quick Look
BARRIERS ASSOCIATED WITH THE TREATMENT OF HEPATITIS C VIRUS INFECTION AMONG ILLICIT DRUG USERS